Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,882,502
-
Share change
-
-92,591
-
Total reported value
-
$7,963,000
-
Put/Call ratio
-
24%
-
Price per share
-
$0.73
-
Number of holders
-
45
-
Value change
-
-$88,102
-
Number of buys
-
17
-
Number of sells
-
20
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q3 2022
As of 30 Sep 2022,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,882,502 shares.
The largest 10 holders included
ETF MANAGERS GROUP, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Mirae Asset Global Investments Co., Ltd., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, Penserra Capital Management LLC, and TWO SIGMA ADVISERS, LP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.